Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Botanical or Research material or [[:Category:Diphenylmethane_laxatives|Diphenylmethane laxative]]

Use the filters below to narrow your results.

generic:
brand:
None (153) · (none, never marketed) (1) · Dulcolax, Correctol, Bisac-Evac (1) · O-DSMT (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) · Monoamine releasing agent (9) · GABAA positive allosteric modulator (8) · CB1/CB2 agonist (7) · Dopamine/norepinephrine reuptake inhibitor (5) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · Serotonin/norepinephrine/dopamine releasing agent (3) · Cathinone analogue; monoamine reuptake inhibitor (2) · Contains LSA (2) · Contains mescaline (2) · Dopamine and norepinephrine reuptake inhibitor (2) · NMDA antagonist (2) · Prodrug of GHB (2)
uses:
None (154) · No approved medical problem. Encountered as a designer/research benzodiazepine and, increasingly, as an adulterant in illicit opioid supplies. (1) · '"`UNIQ--vote-00001069-QINU`"', '"`UNIQ--vote-0000106A-QINU`"' (1)
starting dose:
None (154) · 5-15 mg PO once at bedtime; 10 mg PR for faster effect; bowel prep regimens use higher single doses (1) · No medical dose. Active recreational doses reported in the 0.5–1.5 mg range (similar potency to alprazolam). (1)
preparations:
None (154) · 5 mg enteric-coated tablets; 10 mg rectal suppositories; OTC and Rx (1) · Illicit tablets ("bars"), powders, blotter, occasionally solutions. No pharmaceutical product exists. (1)
fda max:
None (154) · 30 mg/d for short-term use (1) · N/A (never approved) (1)
routes:
None (154) · intranasal; rectal and IV reported. (1) · Oral (2) · rectal (1) · sublingual (1)
onset:
None (154) · PO 6-12 hours; PR 15-60 minutes (1) · ~20–40 min PO; faster sublingual/intranasal. (1)
duration:
None (154) · 6–10 h subjective; full pharmacologic effect considerably longer. (1) · Hours (1)
halflife:
None (154) · Estimated ~12–17 h (some sources cite up to ~21 h); active metabolites prolong effect. (1) · Variable; effect dependent on local intestinal action rather than systemic kinetics'"`UNIQ--ref-0000106B-QINU`"' (1)
bioavailability:
None (154) · Low systemic absorption (enteric coating delivers drug to colon)'"`UNIQ--ref-0000106C-QINU`"' (1) · Not formally characterized in humans. (1)
pregnancy:
None (154) · Avoid. Benzodiazepines are associated with neonatal sedation, floppy-infant syndrome, and withdrawal; teratogenic signal weak but non-zero. Designer benzo with no safety data, assume worst-case. (1) · Generally considered acceptable for short-term use.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
None (155) · OTC in US (1)

Showing below up to 156 results in range #1 to #156.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"